Persistence Market Research

Neurostimulation Devices Market - Global Study on Neurostimulation
Devices - Deep Brain Stimulation Devices to Witness Highest Growth by

2020
Persistence Market Research
Global Neurostimulation Devices Market Will

Reach US$ 10,445.7 million by 2020:

2020
Released New Market Report
Global
Market
Study
on
Neurostimulation Devices - Deep Brain Stimulation Devices to Witness Highest Growth by

2020, the global neurostimulation devices market was valued at US$ 5,088.9 Mn in 2014
and is expected to grow at a CAGR of 12.7% from 2014 to 2020, to reach US$ 10,445.7 Mn
by 2020.
Browse
the
full
Neurostimulation
Devices
Market
report
at
http://www.persistencemarketresearch.com/market-research/neurostimulation-devices-market.asp
Neurostimulation technology involves the use of microelectrodes to activate elements of the
nervous system. It involves the use of a neurostimulation device - a battery-powered
stopwatch-sized device - which is surgically implanted in the brain and delivers electric
signals at scheduled time intervals to the nervous system. These electric signals develop
tingling sensations (paresthesia) in the damaged nerve and helps chronic pain and
neurological disorders. In chronic pain conditions, these electric signals block the pain
messages from the damaged nerve from reaching the brain. These devices are gaining
importance in the management of chronic conditions such neuropathic pain, nociceptive
pain, Parkinsons disease, epilepsy, and depression. Neuropathic pain occurs due to nerve
damage, while nociceptive pain arises from diseases such as diabetes, cancer, and arthritis.
These devices are mostly used in cases where systemic drug therapies are not effective.
The global neurostimulation devices market is witnessing significant growth due to
increasing prevalence of chronic pain and rising incidences of neurological diseases.
Moreover, rising awareness about various neurological diseases, growing geriatric
population, and increasing investments in research and development of innovative
neurostimulation devices are also driving the market. However, availability of alternative
treatment therapies for neurological diseases and side-effects of neurostimulation therapy
inhibit the growth of the market. The global neurostimulation devices market is anticipated
to grow from an estimated US$ 5,088.9 Mn in 2014 to US$ 10,445.7 Mn by 2020 at a CAGR
of 12.7% during the forecast period.
In North America, the neurostimulation devices market is growing due to increasing
incidence of neurological diseases such as Alzheimer and Parkinsons disease. Moreover,
initiatives taken by various government and private associations for increasing awareness
about various chronic pain and neurological disorders and rising investments in the research
and development of novel neurostimulation devices in North America is driving the market in
the region.

2020
The neurostimulation devices market in Europe is growing due to initiatives taken by various
governments to improve healthcare facilities in the region. Furthermore, increasing
incidences of chronic pain and neurological diseases and growing aging population are also
boosting the growth of the Europe neurostimulation devices market. According to WHO,
every year, neurological disorders affect one-third of the population in Europe, and
approximately 1% to 2% of the population is diagnosed with psychotic disorders. According
to the NHS England - a government organization primarily involved in the improvement of
healthcare services in England - approximately 8 million people suffered from chronic pain in
the U.K. in 2010, and the number reached 14 million in 2012.
Request
neurostimulation
devices
market
http://www.persistencemarketresearch.com/samples/2824
Sample
Report
at
Asia Pacific represents the fastest-growing region in the neurostimulation devices market.
This is primarily due to growing aging population in various countries such as India and
China. According to the National Institutes of Health (NIH) - an organization involved in
biomedical and health related research activities - approximately 110 million people in China
were aged 65 years and above in 2011 and the number is expected to reach 330 million by
2050. In India, approximately 60 million people were aged 65 years and above in 2011 and
the number is expected to reach 227 million by 2050.
Medtronic, plc, St. Jude Medical, Inc, Boston Scientific Corporation, and Cyberonics, Inc. are
some of the leading players in the neurostimulation devices market. Other major players of
neurostimulation devices market include Cochlear, Ltd., NDI Medical, LLC, NeuroPace, Inc.,
NeuroSigma, Inc., and MED-EL.
The global neurostimulation devices market is segmented as follows:
By device type
Implantable device
External device
By implantable devices
Spinal cord stimulation (SCS)
Deep brain stimulation (DBS)
Sacral nerve stimulation (SNS)

2020
Vagus nerve stimulation (VNS)

Cochlear implants (CI)
Gastric electric stimulation (GES)
Others
By external devices
Transcutaneous electrical nerve stimulation (TENS)
Transcranial magnetic stimulation (TMS)
Others
By application
Pain management
Parkinsons disease
Urinary and fecal incontinence
Epilepsy
Hearing loss
Gastroparesis
Depression
Others
By geography
North America
Europe
Asia Pacific
Rest of the World (RoW)
Market History:
Neurology is a branch of medical science that deals with the diagnosis and treatment of diseases of
central nerves system (CNS), autonomic nerves system (ANS), and peripheral nervous system (PNS)
through medications and neurostimulation devices.

2020
A neurostimulation device delivers mild electronic signals to the nervous system, which develops tingling
sensations (paresthesia) in the damaged nerve and helps in the treatment of chronic pain and
neurological disorders.
The global neurostimulation devices market is witnessing significant growth due to increasing prevalence
of chronic pain and rising incidences of neurological diseases. Moreover, rising awareness about various
neurological diseases, growing geriatric population, and increasing investments in research and
development of innovative neurostimulation devices are the other factors driving the market. However,
availability
of
alternative
treatment
therapies
for
neurological
diseases
and
side-effects
of
neurostimulation therapy inhibits the growth of the market.

The global neurostimulation devices market is anticipated to grow from an estimated US$ 5,088.9 Mn in
2014 to US$ 10,445.7 Mn by 2020 at a CAGR of 12.7% during the forecast period.
North America is the largest market, while Asia Pacific represents the fastest-growing market for
neurostimulation devices. Spinal cord stimulation (SCS) represents the largest segment, while deep brain
stimulation (DBS) is the fastest-growing implantable neurostimulation device sub-segment in the market.
Transcutaneous electrical nerve stimulation (TENS) is the largest and fastest-growing external device
sub-segment in the market. In terms of application, pain management represents the largest and fastestgrowing application segment in the neurostimulation devices market.
The neurostimulation devices market in North America is anticipated to grow from an estimated US$
2,449.9 Mn in 2014 to US$ 4,892.9 Mn by 2020 at a CAGR of 12.2% during the forecast period.
Table of Content
Chapter 1Preface11
1.1Report Description11
1.2Research Methodology12

2020
1.3Assumptions13
Chapter 2Market Synopsis14
Chapter 3Porters Five Forces Analysis16

3.1Bargaining Power of Suppliers16
3.2Bargaining Power of Buyers17
3.3Threat of New Entrants17
3.4Threat of Substitutes17
3.5Intensity of Rivalry18
Chapter 4Industry Overview19
4.1Market Definition19
4.2Market Drivers20
4.2.1Increasing prevalence of chronic pain20
4.2.2Rise in incidence of neurological disorders21
4.2.3Rising awareness about mental diseases and their treatment21
4.2.4Growing aging population22
4.2.5Increasing R&D investments in novel and innovative neurostimulation devices
developments23

2020
4.2.6Increasing demand for minimally invasive treatment24

4.3Impact Analysis of Market Drivers25
4.4Market Restraints26
4.4.1Availability of alternative treatment therapies for neurological diseases26
4.4.2Side-effects of neurostimulation devices26
4.5Impact Analysis of Market Restraints27
4.6Opportunities27
4.6.1Emerging markets hold major potential27
Chapter 5Global Market Size and Forecast28
Chapter 6Market Size and Forecast, by Device Type39
6.1Implantable device39
6.2External devices41
Chapter 7Market Size and Forecast, by Implantable Devices44
7.1Spinal Cord Stimulation44
7.2Deep Brain Stimulation46
7.3Sacral Nerve Strimulation48
7.4Vagus Nerve Stimulation50

2020
7.5Cochlear Implants52
7.6Gastric Electric Stimulation54
Chapter 8Market Size and Forecast, by External Devices57

8.1Transcutaneous Electrical Nerve Stimulation57
8.2Transcranial Magnetic Stimulation59
Chapter 9Market Size and Forecast, by Application62
9.1Pain Management62
9.2Parkinsons Disease64
9.3Urinary and Fecal Incontinence66
9.4Epilepsy68
9.5Hearing loss70
9.6Gastroparesis72
9.7Depression74
Chapter 10Market Size and Forecast, by Geography77
10.1North America77
10.2Europe80

2020
10.3Asia Pacific83
10.4Rest of the World (RoW)85
Chapter 11Competitive Scenario88

11.1Competitive Benchmarking88
Chapter 12Company Profiles91
12.1Medtronic plc91
12.1.1Company overview91
12.1.2Products and services92
12.1.3Financial performance93
12.1.4Key developments93
12.2St. Jude Medical, Inc.94
12.3Boston Scientific Corporation96

2020

12.4Cyberonics, Inc.99
12.5Cochlear, Ltd.101
12.6NeuroPace, Inc.103
10

2020
12.7NeuroSigma, Inc.105
12.8NDI Medical, LLC107
12.9MED-EL109
List of Tables
11

2020
TABLE 1Market snapshot: Neurostimulation devices market, 2014 and 202014

TABLE 2Drivers for neurostimulation devices market: Impact analysis25
TABLE 3Restraints for neurostimulation devices market: Impact analysis27
TABLE 4Global neurostimulation devices market size, by region, 2010 2013 (USD million)29
TABLE 5Global neurostimulation devices market size, by region, 2014 2020 (USD million)29
TABLE 6Global neurostimulation devices market size, by type of devices, 2010 2013 (USD
million)30
TABLE 7Global neurostimulation devices market size, by type of device, 2014 2020 (USD
million)31
TABLE 8Global neurostimulation devices market, by implantable devices, 2010 2013 (USD
million)32
TABLE 9Global neurostimulation devices market, by implantable devices, 2014 2020 (USD
million)33
TABLE 10Global neurostimulation devices market, by external devices, 2010 2013 (USD
million)34
TABLE 11Global neurostimulation devices market, by external device type, 2014 2020
(USD million)35
TABLE 12Global neurostimulation devices market, by application type, 2010 2013 (USD
million)37
TABLE 13Global neurostimulation devices market, by application type, 2014 2020 (USD
million)38
12

2020
TABLE 14Global implantable device market size, by region, 2010 2013 (USD million)40
TABLE 15Global implantable devices market size, by region, 2014 2020 (USD million)41
TABLE 16Global external devices market size, by region, 2010 2013 (USD million)42
TABLE 17Global external devices market size, by region, 2014 2020 (USD million)43
TABLE 18Global SCS market size, by region, 2010 2013 (USD million)45
TABLE 19Global SCS market size, by region, 2014 2020 (USD million)45
TABLE 20Global DBS market size, by region, 2010 2013 (USD million)47
TABLE 21Global DBS market size, by region, 2014 2020 (USD million)48
TABLE 22Global SNS market size, by region, 2010 2013 (USD million)49
TABLE 23Global SNS market size, by region, 2014 2020 (USD million)50
TABLE 24Global VNS market size, by region, 2010 2013 (USD million)51
TABLE 25Global VNS market size, by region, 2014 2020 (USD million)52
TABLE 26Global CI market size, by region, 2010 2013 (USD million)53
TABLE 27Global CI market size, by region, 2014 2020 (USD million)54
TABLE 28Global GES market size, by region, 2010 2013 (USD million)55
TABLE 29Global GES market size, by region, 2014 2020 (USD million)56
TABLE 30Global TENS market size, by region, 2010 2013 (USD million)58
13

2020
TABLE 31Global TENS market size, by region, 2014 2020 (USD million)58
TABLE 32Global TMS market size, by region, 2010 2013 (USD million )60
TABLE 33Global TMS market size, by region, 2014 2020 (USD million)60
TABLE 34Global pain management market size, by region, 2010 2013 (USD )63
TABLE 35Global pain management market size, by region, 2014 2020 (USD million)64
TABLE 36Global Parkinsons disease market size, by region, 2010 2013 (USD million)65
TABLE 37Global Parkinsons disease market size, by region, 2014 2020 (USD million)66
TABLE 38Global urinary and fecal incontinence market size, by region, 2010 2013 (USD
million)67
TABLE 39Global urinary and fecal incontinence market size, by region, 2014 2020 (USD
million)68
TABLE 40Global epilepsy market size, by region, 2010 2013 (USD million)69
TABLE 41Global epilepsy market size, by region, 2014 2020 (USD million)70
TABLE 42Global hearing loss market size, by region, 2010 2013 (USD million)71
TABLE 43Global hearing loss market size, by region, 2014 2020 (USD million)72
TABLE 44Global gastroparesis market size, by region, 2010 2013 (USD million)73
TABLE 45Global gastroparesis market size, by region, 2014 2020 (USD million)74
TABLE 46Global depression market size, by region, 2010 2013 (USD million)75
14

2020
TABLE 47Global depression market size, by region, 2014 2020 (USD million)76
TABLE 48North America neurostimulation devices market size, by country, 2010 2013 (USD
million)79
TABLE 49North America neurostimulation devices market size, by country, 2014 2020 (USD
million)80
TABLE 50Europe neurostimulation devices market size, by country, 2010 2013 (USD
million)82
TABLE 51Europe neurostimulation devices market size, by country, 2014 2020 (USD
million)82
TABLE 52Asia Pacific neurostimulation devices market size, by country, 2010 2013 (USD
million)84
TABLE 53Asia Pacific neurostimulation devices market size, by country, 2014 2020 (USD
million)85
TABLE 54RoW neurostimulation devices market size, by country, 2010 2013 (USD
million)86
TABLE 55RoW neurostimulation devices market size, by country, 2014 2020 (USD
million)87
TABLE 56Product categories of Medtronic plc92
TABLE 57Product categories of St. Jude Medical, Inc94
TABLE 58Product categories of Boston Scientific Corporation97
TABLE 59Product categories of Cyberonics, Inc99
15

2020
TABLE 60Product categories of Cochlear, Ltd.101

TABLE 61Product categories NeuroPace, Inc.103
TABLE 62Product categories of NeuroSigma, Inc.105
TABLE 63Product categories of NDI Medical, LLC107
TABLE 64Product categories of MED-EL109
List of Figures
FIG. 1Neurostimulation devices market: Porters five forces analysis16
FIG. 2Aging population in major countries, 2000 2050 (% share of total population)23
FIG. 3Global neurostimulation devices market share, by region, by value, 201328
FIG. 4Global neurostimulation devices market share, by type of devices, by value, 201330
FIG. 5Global neurostimulation devices market share, by implantable devices, by value,
201331
FIG. 6Global neurostimulation devices market share, by external devices, by value, 201334
FIG. 7Global neurostimulation devices market share, by application type, by value, 201336
FIG. 8Global implantable device market share, by region, by value, 201339
FIG. 9Global external devices market share, by region, by value, 201342
FIG. 10Global SCS market share, by region, by value 201344
16

2020
FIG. 11Global DBS market, by region 2013 (% share)47
FIG. 12Global SNS market share, by region, by value 201349
FIG. 13Global VNS market share, by region, by value, 2013 (% share)51
FIG. 14Global CI market share, by region, by value, 2013 (% share)53
FIG. 15Global GES market share, by region, by value, 2013 (% share)55
FIG. 16Global TENS market share, by region, by value, 2013 (% share)57
FIG. 17Global TMS market share, by region, by value, 201359
FIG. 18Global pain management market share, by region, by value, 201362
FIG. 19Global Parkinsons disease market share, by region, by value, 201365
FIG. 20Global urinary and fecal incontinence market share, by region, by value, 201367
FIG. 21Global epilepsy market share, by region, by value, 201369
FIG. 22Global hearing loss market share, by region, by value, 201371
FIG. 23Global gastroparesis market share, by region, by value, 201373
FIG. 24Global depression market share, by region, by value, 201375
FIG. 25North America neurostimulation devices market share, by country, by value, 2013 (%
share)79
FIG. 26Europea neurostimulation devices market share, by country, by value, 2013 (%
share)81
17

2020
FIG. 27Asia Pacific neurostimulation devices market share, by country, by value, 2013 (%
share)84
FIG. 28RoW neurostimulation devices market share, by country, by value, 2013 (% share)86
FIG. 29Leading players and their product offerings in the market88
FIG. 30Overall market presence and focus on neurostimulation business89
FIG. 31Sales and net earnings of Medtronic, plc, 2012 2014 (USD Million)93
FIG. 32Net sales and net earnings of St. Jude Medical, Inc, 2011 2013 (USD Million)95
FIG. 33Net sales and net income/loss of Boston Scientific Corporation, 2011 2013 (USD
Million)98
FIG. 34Net sales and net income of Cyberonics, Inc, 2011 2013 (USD Million)100
FIG. 35Revenue and net profit of Cochlear, Ltd., 2011 2013 (USD million)102
About Us:
Persistence Market Research is a global market research firm specializing- syndicated research,
custom research, and consulting services
At Persistence Market Research (PMR), we are in the business of accelerating your business. As a fullservice market research firm, we stand committed to bringing more accuracy and speed to your business
decisions. From ready-to-purchase market research reports to customized global research solutions, our
engagement models are highly flexible without compromising on our deep-seated research values. Briefly
stated, our mission is to give you access to forecasts and trends analyses that put you on the path to
profitability.
PMRs Services Go Beyond Gleaning Data
18

2020
Most enterprises believe that IT and databases are enough to make an accurate decision. While we do
not dispute that, consider this: How long does it take to make an accurate and strategic million-dollar
decision? We strive to deliver both even with demanding deadlines.
Contact Us:
Addie Thomes
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA - Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
19

Persistence Market Research

Diunggah oleh

Informasi Dokumen

Deskripsi Asli:

Judul Asli

Hak Cipta

Format Tersedia

Bagikan dokumen Ini

Bagikan atau Tanam Dokumen

Opsi Berbagi

Apakah menurut Anda dokumen ini bermanfaat?

Apakah konten ini tidak pantas?

Hak Cipta:

Format Tersedia

Persistence Market Research

Diunggah oleh

Hak Cipta:

Format Tersedia

Neurostimulation Devices Market - Global Study on Neurostimulation

Devices - Deep Brain Stimulation Devices to Witness Highest Growth by